Annual Governance Statement
This section of the annual report will cover:
- Scope of responsibilties and the risk and control framework
- Freedom to speak up
- System working and partnerships
- Review of economy, efficiency and effectiveness of the use of resources
- Directors’ report - Composition of the Board of Directors
- Review of effectiveness
Scope of Responsibility
As Accountable Officer, I have responsibility for
maintaining a sound system of internal control that supports the achievement of
the NHS trust’s policies, aims and objectives, while safeguarding the public
funds and departmental assets for which I am personally responsible, in
accordance with the responsibilities assigned to me. I am also responsible for
ensuring that the organisation is administered prudently and economically and
that resources are applied efficiently and effectively. I also acknowledge my
responsibilities as set out in the NHS trust Accountable Officer Memorandum.
The purpose of the system of internal control
The system of internal control is designed to manage risk to
a reasonable level rather than to eliminate all risk of failure to achieve
policies, aims and objectives; it can therefore only provide reasonable and not
absolute assurance of effectiveness. The system of internal control is based on
an ongoing process designed to identify and prioritise the risks to the
achievement of the policies, aims and objectives of Lincolnshire Community
Health Services NHS Trust, to evaluate the likelihood of those risks being
realised and the impact should they be realised, and to manage them
efficiently, effectively and economically.
The system of internal control has been in place in
Lincolnshire Community Health Services NHS Trust for the year ended 31 March
2022 and up to the date of approval of the annual report and accounts.
Capacity to handle risk
The trust has a Risk Management Strategy which is approved
by the trust Board.
The trust Risk Management Strategy has been reviewed by key
stakeholders and risk champions within LCHS and proposed revisions discussed in
assurance groups and trust Committees prior to ratification by the trust Board
in March 2022. This included a full review and realignment of the trust’s Risk
Appetite Statement following board development sessions in-year and testing the
2021-22 risk appetite alignment to strategic objectives through Board decision
discussions during the year.
The strategy is available to the public and employees on the trust website. The purpose of the
strategy is to ensure that risks and issues to the quality and delivery of
patient services and care are managed to protect the services, reputation and
finances of the trust, to create a culture where staff acknowledge risk as the
responsibility of everyone and to ensure that the trust meets its statutory
obligations. The strategy defines the structures for the identification,
management, ownership, review of risks and issues along with risk criteria,
control and gaining assurance of risk or issue and the methods in which risks
and issues are considered, assessed and mitigated.
The risk management process is owned by trust Board with
Executive Directors and Deputy Directors being directly accountable for each
risk and issue and for the appropriate and effective mitigating actions, in line
with the Corporate Governance Code and the Orange Book, principles and concepts
of risk management. All risks with an overall score of 12 or above are noted on
the trust Corporate Risk Register are reviewed at least monthly by Deputy
Directors in collaboration with Executives.
Feeding into this is the Corporate Operational Risk Register for risks
holding an overall score of 4 to 11, monitored through the trust Leadership
Team on a monthly basis and informed by local risk registers held by divisions
with support from Quality Assurance Managers and/ or risk owners for corporate
functions. Robust mechanisms are in
place to ensure risks are managed effectively, moved between registers
appropriately and to ensure sufficient time is allocated by each responsible
committee or group for their consideration, review and management.
Through the risk identification process staff at all levels
are able to identify, assess and develop mitigating action plans to reduce and
manage each risk or issue effectively. The Risk Management Strategy provides
the overarching framework and guidance to enable this along with training and
support provided by the Corporate Governance and Quality Teams. The Deputy
Directors, Divisional Leads, Heads of Service, Specialist Advisors and Quality
Assurance Managers play a key role, individually and collaboratively, in effecting
consistency in the assessment of risks and issues, the escalation and
improvement of risks and issues and their subsequent movement onto and between
LCHS corporate risk registers.
The risk and control framework
The system of internal control is designed to manage risk to
a reasonable level rather than to eliminate all risk of failure to achieve
policies, aims and objectives. The
organisation’s Risk Appetite Statement is published on the website and reviewed
periodically while the various risk registers are considered in its context.
The trust Board is responsible for the management of key
risks. The key areas of those risks are managed through:
- Corporate Risk Registers
- Large Vaccination Centre Risk Register
- Board Assurance Framework
- Financial risk management
- Compliance with targets
- Single Oversight Framework
- Operational Delivery Plan
- Performance management reporting.
The trust’s approach to corporate governance is rooted
within best practice and is regularly reviewed and assessed through internal processes. While the Strategy was collaboratively
rewritten and published in March 2022 regular reports at every meeting of the trust Board reflect developments, movement and mitigations of risks, issues and
improvements to control arrangements. The Corporate Risk Register is reviewed
and approved by the trust Board as part of this process and in each public
board meeting. A significant development
during 2021-22 has been the development and investment to strengthen local risk
registers for digital and information governance and consolidation of the
clinical services local risk registers with the corporate operational risk
register (May-July 2021). Regular Deputy Director huddles, risk and control
management forming a key part of these discussions, have supported the
development of the risk culture and promoted collective as well as individual
responsibility at the highest level and consistency in assessment.
Among the key high-scoring risks on the Corporate Risk
Register during 2021-22 were:
- Risk to community nursing and capacity due to vacancy gaps, the time between recruitment and start dates, sickness and self-isolating alongside an increase in demand for the service which could result in possible failures to identify and monitor deterioration in patients leading to an impact on patient safety.
- Risk that staffing levels are not sufficient to meet demand in urgent care services due to increase in demand for the service, staff sickness, self-isolation and vacancies that could result in a negative patient experience and potential for patient harm as well as loss of staff moral and possible closure of departments.
- Risk to service sustainability and deliverability due to future changes to commissioning, with the potential to result in reduction in income or opportunity to invest, affecting financial viability of the trust and its services.
- Risk that trust services are disrupted due to the NHS or the trust being targeted in a cyber-attack which could result in significant disruption to clinical and corporate services if systems fail.
- Risk of delay in providing initial health assessments for looked after children and children in care in Lincolnshire caused by a lack of consistent General Practice resource with suitable training to undertake assessments, resulting in health and safeguarding implications on the children and potential impact on their wellbeing and future development
- Risk that the delivery of the two large vaccination sites in Lincolnshire under the trust’s Care Quality Commission’s registration may impact negatively on quality governance reporting and the trust’s reputation due to the organisation working with Lincolnshire partners differently and where the trust is not the leading operational provider or employing organisation and could result in loss of oversight assurance for patient safety, potential patient harm and reputational damage. urgent and emergency care services across Lincolnshire could become overwhelmed due to periods of high activity, resulting in patient safety issues.
Of the high-scoring
risks from 2021-22 detailed above, mitigating actions for each risk continue to
be implemented, such as the significant recruitment of additional staff in
community nursing and urgent care teams. Nonetheless, additional programmes such
have also seen investment from teams, such as the urgent community response
programme. The remaining risks continue to be managed and reviewed regularly.
- Additional high-rating risks during 2021-22 that were closed or mitigated to the extent of movement to corporate operational or local risk registers were:
- Risks relating to the trust and system response to Covid-19, such as the provision of personal protective equipment, the restoration of services and the trust’s lead provider role for the two Lincolnshire large vaccination centres based in Boston and Lincoln.
- Risk that the inadequate maintenance of the NHS Property Services-owned estate could result in a loss of service and/or damage to persons.
- Risk that urgent and emergency care services across Lincolnshire could become overwhelmed due to periods of high activity, resulting in patient safety issues.
- Risk that patients treated within LCHS services could deteriorate due to delays while awaiting ambulance transfer, resulting in patient harm.
- Risk that the UK left the EU with either ‘no deal’ or a deal and the possible impact upon LCHS activity, with potential to result in significant disruption to services, supply, business delay and logistics. This was revised post securing an exit agreement.
- Risk that the trust will not have the capacity or competencies within teams to effectively respond to the anticipated Children and Young People (CYP) Respiratory Surge in Winter 2021/22 due to respiratory viral infection, identified anticipated challenges of an increased prevalence of paediatric respiratory viral infections that could impact of patient safety of children and young people.
LCHS is passionate
about learning from risk management and during the 2021-22 year the deputy
director of corporate governance has been working with teams and leaders across
the organisation to provide advice about risk management, develop understanding
of definitions of risks and issues, the differences between controls for a risk
and actions to mitigate and supporting through coaching methodology. The
governance structure and Matters Reserved for the Board and Scheme of
Delegation set out the route, responsibilities and accountabilities of trust
Board, Committees and Specialist Groups for risk management and the escalation
and improvement of risks and issues. Ensuring corporate and local risk registers
and the trust Board Assurance Framework frame each agenda has helped to embed
the risk management culture of the trust. Additional support to staff at all
levels has been provided throughout the year to support identification,
ownership of risk and appropriate escalation of risks and issues. It is planned
that this will continue throughout 2022-23 as a further risk management
training programme is piloted develop knowledge, competence and ownership of
the risk process and increase the quality and responsiveness to risk reporting
and mitigation activities.
There is a robust
Board Assurance Framework in place which sets out the key controls and
assurances on controls to safeguard against the key risks to the achievement of
the strategic aims and objectives. The Board Assurance Framework is aligned to
the organisation’s Operational Plan and is reviewed at every meeting of trust
Board and its assurance committees. In
addition, there are formal risk management procedures in place with effective
review and management procedures which incorporate both a controls assurance
and a risk assessment.
The committees of
the trust Board – the Quality and Risk Committee (QRC) and the Finance,
Performance, People and Innovation Committee (FPPIC) – assess each and every
business item against the Board Assurance Framework. This enables direct assessment against compliance
on all fronts, including CQC requirements.
The committees review the corporate risk register monthly, with an
overall score of 12 or above, in addition to risks on the corporate operational
risk register, with an overall score 4-11, where the trust risk appetite is noted
as ‘cautious’. The trust has a cautious
risk appetite for risks and issues relating to patient safety or harm, staff
safety and wellbeing, cyber security, health and safety and recruitment
compliance. Board members agreed when reviewing and setting the 2022 risk
appetite that upward reporting from committees to Board will identify such
risks that require Board’s attention on the corporate operational risk
register.
The Risk Management Strategy and the trust Governance Manual (Standing Orders, Standing Financial Instructions and the Matters Reserved to the Board and Scheme of Delegation) stipulate the accountability for risk management and approval of changes to the Corporate Risk Register lies with trust Board. Operational management and oversight for the Corporate Operational Risk Register (CORR) resides with TLT.
Separately, the
People Executive Group (PEG), chaired by the Executive Director of People, has
delegated responsibility for ensuring the trust has developed and managed the
short, medium and long-term workforce strategies and staffing systems to comply
with the ‘Developing Workforce Safeguards’ recommendations. In addition, PEG has provided People Strategy
progress reports, assurance reports and updates risks and work-plans to FPPIC.
All policies approved by this forum are able to be escalated to Board for
endorsement and/or challenge. Quality and Equality Impact Assessments are
completed to assess substantive changes to workforce or services and are
reviewed and approved through the Quality and Equality Impact Assessments
Panel, which reports into QRC.
Sharing the learning
gained through risks and issues, incidents, complaints and claims management
processes is an essential component to maintaining the risk management culture
within the trust. Learning is shared through divisional and corporate
structures and trust-wide governance committees and groups as outlined in the trust organisational structure. Assurance and learning conversations take place
in local assurance groups, such as the Quality Assurance Groups that support
each clinical division, and report into specialist groups like the Stakeholder,
Engagement and Involvement Learning from Deaths, Drugs and Therapeutics Group
and the Health and Safety Committee.
Learning is acquired
from a variety of sources which include:
- analysis of incidents, complaints, claims and acting on the findings of investigations
- quality impact assessments
- equality impact assessments
- external Inspections
- internal and external audit reports
- clinical audits
- outcome of investigations and inspections relating to other organisations.
Freedom to speak up
Our Freedom to
Speak Up Guardian (FTSUG) is well embedded into the trust and plays a lead role
in engagement and interaction with our staff. This role supports the organisation
in complying with the outcomes set up by the National Guardian Office (NGO) and
the outcomes include:
- A culture of speaking up being instilled throughout
the organisation.
- Speaking up processes are effective and
continuously improved.
- All staff have the capability to speak up effectively
and managers have the capability to support those who are speaking up.
- All staff are supported appropriately when they
speak up or support other people who are speaking up.
- The Board is fully sighted on, and engaged in, all
freedom to speak up matters and issues that are raised by people who are
speaking up.
- Safety and quality are assured.
- Question 17a, I would feel secure raising concerns about unsafe practice – 82.6% slight increase from 82.5% in 2020, UK average 83.1%.
- Question 17b, I am confident my organisation would address my concerns - 72.5% decrease from 74.8% in 2020, UK average 72.4%.
- Question 21e, I feel safe to speak up about anything that concerns me in this organisation – 73.3% a decrease from 74.2% in 2020, UK average 71.4%.
- Question 21f, (new question for 2021) If I spoke up about something in my organisation I am confident my organisation would address my concerns - 63.1% - highest being 69.2% and lowest 48.6%.
Analysis enables targeted work in areas identified and has resulted in additional FTSUG hours.
12 Principles for Responding to Speaking up have beenintroduced and utilised by the FTSUG.
NGO Principles for Responding to Speaking Up
- There will be clear and accessible information on
how to speak up.
- Speaking up processes will be designed so that all
workers can speak up easily.
- Everyone who speaks up will be thanked.
- Where appropriate, workers will be encouraged and
supported to speak up locally.
- If another organisation (e.g., another national
body) better addresses a matter, workers will be supported to speak up to
that organisation.
- Workers will be offered information on other
sources of advice and support.
- Workers speaking up will be provided with a
response in a timeframe that is made clear to them.
- Responses to speaking up will include details
setting out how the information provided was used for learning and
improvement.
- The confidentiality of those who speak up will be
respected, subject to the need to ensure safeguarding requirements are
met.
- Where matters are raised anonymously, they will be
responded to in accordance with these principles to the extent possible.
- Workers will be given the opportunity to feedback
on their experience of speaking up.
- The speaking up arrangements’ effectiveness will be monitored, and opportunities to improve taken.
Annual contact numbers
The number of contacts continue to increase year on
year as the role has become embedded, and senior leaders across the trust are
referring to the guardian as part of everyday communications where relevant.
As with previous years the greatest number of contacts were pertaining to staff experience. Any patient safety or quality issues were small in number, detailed later in the report and related to staffing levels, which were rapidly escalated.
Year |
Contacts |
2018/2019 |
24 |
2019/2020 |
29 |
2020/2021 |
60 |
2021/2022 |
94 |
Themes of contacts
Note: Staff experience includes behaviours,
bullying, relationships and working conditions.
Worker safety
includes health and safety at work and emotional wellbeing issues.
Only one contact was pertaining to COVID-19 and that was resulting from redeployment issues.
Staff role
Of the 48
nurse contacts 21 were band 7 or above. From the above contacts the majority
came directly to the FTSUG other areas that signposted or directed contacts to
the FTSUG are:
- Leavers questionnaire 7
- Champions network 7
- Staffside 3
- Staff networks 2
One case expressed detriment which has been rapidly escalated.
Service area breakdown
Summary of
FTSUG activity |
Action/Outcome/Narrative |
Civility and
Respect |
FTSUG has key
involvement in the dignity and civility agenda, has developed a civility
charter tool and produced a webinar on the effects of incivility on safety
and quality in patient care and the impact on staff wellbeing. |
Inclusion in
leavers questionnaire |
FTSUG is
named as an option for follow up contact on all exit/leavers questionnaires
and this has generated increased contacts during the reporting period. It has
enabled the organisation to gain understanding of reasons for leaving,
provided opportunities to retain staff and allowed reflection on feedback to
improve experiences. |
Group of clinical
team leaders a given voice and bespoke access at director level |
Outcome -
Very positive feedback, felt speaking up has been career enhancing, greater
understanding for both parties and ability to provide solutions. |
Multiple area
contacts, theme specific |
Four bespoke
listening events have been initiated by the FTSUG where several contacts,
with a recurring theme have emanated from a service area. Principles of
openness, listening and respect, format informal to gain knowledge and
opinions. |
Target areas
of low speak up |
Follow up
from quarterly statistical analysis. Targeting areas where there have been
few or no contacts, carrying out ‘Back to the Floor’ activity or dedicated
sessions, to heighten the FTSUG profile and explore rationale as to why there
are fewer contacts. |
Engage with
managers to improve “speak up responses” |
Every
opportunity utilised to promote use of language, nonauthoritarian approach,
resist seeing through managers prism. Thanking person for speaking up.
Utilise some of the NGO Principles for Responding to Speaking Up. |
Feedback from
staff spoken up about. |
A process has
been implemented, following up those who have been spoken up about, to obtain
information about how we are evolving as a listening, no blame but learn
organisation. |
System
working |
LCHS FTSUG
works in partnership with Lincolnshire FTSUG forum with LPFT and ULHT, to
share themes, develop innovation in the role, access support and provide
external supervision |
Fulfilling the wider objectives
of the trust requires effective partnership working in addition to the internal
governance and control framework. As the Chief Executive, I am
accountable to the trust Board, the Chair and NHS England and Improvement. I am
also accountable, along with the trust Board, to the Secretary of State via NHS
Improvement. Increasingly the trust will be assessed on how well it works with
and through the system it is part of to tackle problems as regulators including
the Care Quality Commission and NHS England and Improvement place a greater
emphasis on system performance and quality of care outcomes.
As such, myself and the board are responsible for ensuring
that the trust works effectively in partnership across the wider health
community in Lincolnshire. Key partnerships include:
- NHS Lincolnshire Clinical Commissioning Group and CCGs in adjoining counties
- The Integrated Care Board designate which will be formally established on 1 July as the CCGs are dissolved and their duties taken into the ICB
- Other health commissioners including the local authority and NHS England
- Lincolnshire Health Scrutiny Committee which reviews and scrutinises health and wellbeing services and their outcomes
- Unions including through the Joint Consultation and Negotiation Committee (JCNC)
- Lincolnshire County Council including adult social care and children’s services
- The 15 Primary Care Networks in Lincolnshire and the Primary Care Network Alliance
- The voluntary, community, and social enterprise sector via the Voluntary Engagement Team
- The independent sector including care home and nursing home providers through Lincolnshire Care Association (LinCA)
- Community and patient representative bodies including Lincolnshire Healthwatch
- Regulators including NHS England and NHS Improvement (NHSEI) and Care Quality Commission
- Infrastructure bodies including NHS Providers and NHS Confederation
- The Better Lives Lincolnshire Executive Team made up of the top leaders from among Lincolnshire health and care providers
- Lincolnshire Health and Care Collaborative, an alliance of health and care providers who will take responsibility for delivering key functions on behalf of the ICB, of which I am co-chair
- Lincolnshire NHS Leaders Group of NHS provider chief executives and chairs and the CCG (ICB after 1 July).
Better Lives Lincolnshire
Better Lives Lincolnshire is the name used for the Integrated
Care System (ICS) in our county. From 1 April 2021 this new partnership brings
together organisations across the NHS, primary care, local authority, the
voluntary, community and social enterprise sector, and independent sector to
collectively improve services and the health and wellbeing of the people of
Lincolnshire. In line with the national aims of ICSs, the Better Lives
Lincolnshire aims to:
- Improve outcomes in population health and healthcare
- Tackle inequalities in outcomes, experience and access
- Enhance productivity and value for money
- Help the NHS support broader social and economic development.
The development
of the Lincolnshire Integrated Care System has also progressed ahead of it formally
coming into effect in July 2022 through the Health and Social Care Act 2022.
The ICS includes the NHS Lincolnshire Integrated Care Board (ICB) and the
Integrated Care Partnership (ICP).
The ICB is a statutory board responsible for developing a plan to meet the health needs of the population, managing the NHS budget and arranging for the provision of health services in the defined area. The ICB will replace the Lincolnshire Clinical Commissioning Group.
The ICB work continues on developing the governance arrangements for the Lincolnshire Integrated Care Board and Integrated Care Partnership. The Integrated Care Partnership is a statutory committee of the ICS whose members support integrated working at a system level and develop a strategy that describes the changes it wants to achieve.
Provider collaboratives
Provider collaboratives are a key
component of system working. They are the main way for providers to work
together to plan, deliver and transform services in an ICS by working at scale to
tackle unwarranted variation, make improvements and deliver the best care for
patients and communities.
The Lincolnshire Health and Care Collaborative (LHCC) has been
established as the provider collaborative for the county that will drive the
improvements in quality of care while ensuring services are integrated and cost
effective. While there may be more than one provider partnership in Lincolnshire,
LHCC is the provider collaborative for Lincolnshire. The context, supported by
new legislation, is changing from competition to partnerships, closer
integration and local collaboration.
This collaborative will be enabled by legislation on 1 July 2022, setting
a platform for driving forward increased collaboration, putting the health and
care needs of residents as priority and taking the opportunity to think
differently, work closer and more efficiently than ever.
The commitment to the residents of Lincolnshire remains the same:
- A healthy population with better information for people to manage their own health, earlier prevention and making sure we tackle inequalities with equitable provision supporting health and wellbeing.
- Strong communities with people and their families included in health and care management, ensuring no one is disadvantaged with good advocacy and support, and ensuring we contribute to making a difference to wider aspects of daily life that can improve people’s health and wellbeing.
- Accessible, integrated, and responsive care, listening to people and treating them holistically, working together in much more joined up approach, fully developing care closer to home. And reducing waiting times for diagnosis, appointment, and test results.
An Alliance Agreement describes how partners will work together to establish
more robust mutual accountability and break down barriers between our separate
organisations.
In the immediate term, the provider collaborative
deliverables include three key transformation programmes that will contribute
to the delivery of the Strategic Delivery Plan which will take Lincolnshire out
of SOF 4. The phase 1 projects are:
- Prescribing including for mental health conditions
- Muscular skeletal problems
- Care closer to home, providing co-ordinated care for patients in their homes or in their local communities that enables residents and patients to keep themselves well, take charge of their own health, whilst maintaining access to high quality care at the right time, with the right specialist support.
As the
Integrated Care Board becomes established it will look to delegate
responsibility for specific functions to the provider collaborative. We anticipate
that these will be:
- Data and digital
- People and culture
- Service delivery, redesign and transformation.
In 2022, the provider collaborative will focus on developing
the next phase of transformation projects that will help Lincolnshire to
deliver its Strategic Delivery Plan to exit SOF 4, and the programmes under the
two other functions.
Organisation’s statutory obligations
The trust is fully compliant with the registration requirements of the Care Quality Commission.
The trust has published on its website an
up-to-date register of interests, including gifts and hospitality, for
decision-making staff (as defined by the trust with reference to the guidance)
within the past twelve months, as required by the ‘Managing Conflicts of
Interest in the NHS’ guidance.
As an employer with staff entitled to
membership of the NHS Pension Scheme, control measures are in place to ensure
all employer obligations contained within the Scheme regulations are complied
with. This includes ensuring that deductions from salary, employer’s
contributions and payments into the Scheme are in accordance with the Scheme
rules, and that member Pension Scheme records are accurately updated in
accordance with the timescales detailed in the Regulations.
Control measures are in place to ensure
that all the organisation’s obligations under equality, diversity and human
rights legislation are complied with.
The trust has undertaken risk assessments and has plans in place which take account of the ‘Delivering a Net Zero Health Service’ report under the Greener NHS programme. The trust ensures that its obligations under the Climate Change Act and the Adaptation Reporting requirements are complied with.
Information Governance
There were no data breach incidents
relating to information governance reported to the Information Commissioner’s
Office (ICO) during 2021/22.
Information Governance Management
Assurance Group (IGMAG), following significant review through 2021-22 to
reflect digital and cyber programmes, data, assurance and risk, has been
renamed to the Digital Executive Group (DEG). The group oversees all
information governance and data protection issues and reports to the Finance,
Performance, People and Innovation Committee whilst also providing assurance to
the trust Board to ensure that legal, statutory and regulatory requirements are
met.
The DEG is chaired by the senior
information risk owner, who is the Director of People and Innovation.
Staff are encouraged
to report data breach incidents and seek further advice and guidance regarding
any additional actions that may need to be taken and implemented.
Mandatory information governance training
follows the Core Skills Training Framework and is an annual requirement for all
staff. Induction training for new starters is delivered through the accredited
e-learning ‘Data Security Awareness Training’ which requires a minimum of
80% pass rate.
Staff are
governed by a code of confidentiality for any data they have access to which is
strictly access controlled to authorised users through National Policy and Role
Based Access Control.
Each IT system,
whether corporate or clinical, has a designated Information asset owner with
defined responsibilities, including risk management for identifying information governance risks.
These are supported by Information asset administrators who provide assistance at a local level.
The submission for the Data Security
and Protection Toolkit was published 11 June 2021 with all standards met and
achieved ‘significant assurance with some improvement required’
from the auditors.
Data quality and governance
The Performance
and Information team, within the Finance and Business Intelligence Directorate,
conduct regular data quality checks on datasets and reports. The team connects
with the national NHS Benchmarking work which enables the trust to benchmark
its own data with that of other trusts to enable comparators and scope for
improvement. The team works closely with the Digital Health team to enable
front-end changes to correlate into meaningful data and analysis. The team also
provide key data that informs Performance Management Reviews, which are
conducted with each division and corporate area to assess performance against
agreed key performance indicators and metrics to drive measurement, review and
improvement.
A Data Quality Group provides the trust with assurance that
the trust’s data and information, provided both internally and externally, is being
carefully monitored and that improvements are being identified and implemented
where necessary. It also enables the trust to demonstrate its commitment to
encouraging a culture of continuous improvement and accountability. The
Finance, People, Performance and Innovation Committee has oversight for the
Data Quality Group (FPPIC) and receives a report from them every 6-8 weeks on data
quality assurance and in relation to the significant work to develop power
business intelligence across the trust. In February 2022 the national ‘Make
Data Count’ team presented trust data using statistical process control tool to
simplify and improve data quality and reporting and reduce spuddling in
assurance meetings, enabling the trust to focus on trends that require action. FPPIC
reports bimonthly into trust Board.
Performance data
and reporting is a key component of FPPIC and Quality and Rick Committee (QRC) assurance, highlighting areas
where key performance indicators and metrics are being achieved and can be
celebrated, or to enable committees to focus attention to inconsistent
performance or where indicators are not being achieved and to prompt
appropriate action to be taken.
Key FPPIC
performance indicators relate to our people, recruitment, health and safety, digital
programmes, access and tackling digital inequalities, strategic planning,
partnership working and feedback from commercial stakeholders and financial
planning.
The Quality and Risk Committee considers a wealth of performance information from complaints, incidents, safeguarding contacts and referrals, compliments, claims received, national Quality Board data, patient friends and family test percentage responses through to collating lessons learned following feedback and demonstrating impact of acting on feedback and learning in service developments.
Chair: Elaine Baylis QPM
Chief Executive: Marie (Maz) Fosh
Executive Directors
- Tracy Pilcher, Director of Nursing, Operations and Allied Health Professionals and Deputy Chief Executive
- Ceri Lennon, Director of People and Innovation
- Sam Wilde, Director of Finance and Business Intelligence
- Dr Yvonne Owen, Medical Director
Non-Executive Directors
- Alan Kent
- Liz Libiszewski (01/04/2021 – 31/10/2021)
- Kevin Lockyer (01/04/2021 – 30/04/2021)
- Gail Shadlock
- Malcolm Burch (from 01/05/2021)
- Murray Macdonald (from 01/07/2021)
- Jim Connolly (from 01/11/2021)
Also in attendance:
- Deputy Director of Corporate Governance
- Corporate Administration Manager and Personal Assistant
The board met
monthly throughout 2021-22 alternating between formal public and private
meetings one month and informal meetings and Board training sessions the next.
A programme of monthly Board development sessions were also rolled out,
evolving in format through the year which resulted in numerous products being
developed, such as an enabling visual graphic, case studies for collaboration
and a Board-approved Board Assurance Framework for 2022-23 by the close of the
financial year. Several of the products developed supported system
conversations and pace in the progression of the Lincolnshire Health and Care
Collaborative. The Board’s main committees – the Quality and Risk Committee and
the Finance, Performance and Investment Committee, whose title was updated
in-year to reflect the transformational nature of the committee to the Finance,
Performance, People and Innovation Committee – also met monthly. The
Remuneration Committee met five times during the year. The Board of
Trustees for Charitable Funds met three times during the year.
Through the Board development programme senior leaders reviewed the trust well-led board, deputy directors and heads of service ratings from the previous financial year in light of the CQC strategy released in May 2021. The session enabled the trust to confirm alignment of the trust strategic aims and objectives to the four areas outlined by the CQC of people and communities, smarter regulation, safety through learning and accelerating improvement. Sessions were rolled out across the trust by the Deputy Director of Nursing and Quality.
Changes to the Board membership in-year were:
- Kevin Lockyer, Non-Executive Director and interim chair of finance, performance and investment committee, left the trust on 30 April 2021
- Liz Libiszewski, Non-Executive Director and chair of quality and risk committee, left the trust on 31 October 2021.
- Malcolm Burch, Non-Executive Director, commenced on 1 May
- Murray MacDonald, Non-Executive Director, commenced on 1 July
- Jim Connolly, Non-Executive Director, commenced on 1 November 2021.
In line with the
nationally released guidance in December 2021, LCHS Non-Executive Director
Champion roles were reviewed and agreed in March 2022, excluding the Maternity
Safety Champion role which is not applicable to LCHS:
- Wellbeing Guardian – Gail Shadlock.
- Freedom to Speak Up – Jim Connolly has taken over this role from Liz Libiszewski as previous Quality and Risk Committee Chair related role.
- Doctors Disciplinary –Gail Shadlock.
- Security Management – Malcolm Burch.
Register of directors’ interests
Entry Number |
Name of Employee |
Official Appointment in LCHS |
Nature of Interest (Pecuniary or
Non-Pecuniary) declared |
Current Interest |
Date interest declared |
Date Recorded
|
Date interest ceased |
1 |
|
Chair |
Owner of Baylishill, a performance development coaching
and consultancy business, operated as a sole trading company from home
address. Director & Trustee (Deputy Chair) Chair United Lincolnshire Hospitals NHS Trust Chair of the System Leaders Board (formerly Lincolnshire
Co-ordinating Board) |
Yes No Yes Yes |
13/4/11 24/4/11 1/1/2019 1/3/2018 |
13/4/11 24/4/11 8/1/19 14/4/18 |
30/3/2020 07/02/2022 |
2. |
M Fosh |
Chief Executive |
Chair of the Lincolnshire People Board As chair
of the People Board, connected the Lincolnshire Refugee Doctor Charity with
Simon Burrows, Deputy Director of FBI. Simon is now a non-renumerated trustee
on their board. Chair of the Urgent & Emergency Care Delivery Board CEO Sponsor for Digital SRO for East Midlands One Care Chair of the Digital, Data & Technology Board (DDaT) Co-Chair of the Lincolnshire Health & Care
Collaborative |
Yes Yes Yes Yes Yes Yes |
23/09/20 July 2020 July 2020 01/09/19 25/10/21 25/10/21 |
02/03/21 02/03/21 02/03/21 02/03/21 18/11/21 18/11/21 |
31/3/22 31/3/22 |
3. |
S Wilde |
Director of Finance and Business Intelligence |
Governor – Taplon School Sheffield Member of the HFMA Costing for Value Institute Council Chair – Community Services Reference Group – NHS Benchmarking Network |
No Yes Yes |
1/6/18 10/10/19 10/11/20 |
6/6/18 11/11/19 11/11/21 |
1/5/19 |
4. |
A Kent |
Non-Executive Director |
Director and Shareholder of Litmus Health Limited |
Yes |
31/01/18 |
02/02/18 |
|
5. |
Y Owen |
Medical Director |
LIVES Trustee GP Partner at
East Lindsey Medical Group Salaried GP at
Minster Practice, Lincoln |
Yes Yes Yes |
6/6/18 29/05/20 12/01/21 |
6/6/18 29/05/20 12/01/21 |
31/12/20 |
6. |
T Pilcher |
Director of Nursing, AHPs and Operations |
Senior Responsible Officer – Urgent & Emergency Care
Delivery Board |
Yes |
July 2020 |
02/03/21 |
|
7. |
C Lennon |
Director of People and Innovation |
Senior Responsible Officer – Lincolnshire People Board |
Yes |
Sept 2020 |
02/03/21 |
|
8. |
G Shadlock |
Non-executive Director |
Director of a local community enterprise Interim Non-executive Director – United Lincolnshire
Hospitals NHS Trust Non-executive Director- Eastlight Community Homes |
No Yes Yes |
10/3/2020 8/3/2022 01/5/2022 |
12/3/2020 9/3/2022 03/5/22 |
31/08/21 |
9. |
M Burch |
Non-executive Director |
Chief Executive to the Lincolnshire Police and Crime
Commissioner |
Yes |
26/6/2021 |
06/7/2021 |
|
10. |
M Macdonald |
Non-executive
Director |
Chief Executive
to the Lincolnshire Housing Partnership Chair of Manby
Scouts Association Patient
representative at East Lindsey Medical Practice Director – Humber
Homes Director – Boston
Mayflower PLC |
Yes Yes Yes Yes Yes |
1/7/2021 24/7/2021 24/7/2021 03/5/2022 03/5/2022 |
06/7/2021 12/8/2021 12/8/2021 03/5/2022 03/5/2022 |
|
11. |
J Connolly |
Non-executive Director |
Owner/Managing Director Riverside Consultants Ltd. –
Provider of consultancy support to NHS and Adult Social Care Owner/Director Riverside Coaching and Consultancy Ltd –
Provider of Consultancy Support to Health and Social Care and Individual
Coaching Owner Jim Connolly Photography Ltd Contractor of Services, as a vaccinator to K2 Healthcare. Specialist Advisor - CQC Wife is Associate Director of Nursing NHSE Midlands region
|
Yes Yes Yes Yes Yes Yes |
9/11/2021 9/11/2021 9/11/2021 9/11/2021 9/11/2021 9/11/2021 |
11/11/2021 11/11/2021 11/11/2021 11/11/2021 11/11/2021 11/11/2021 |
|
As Accountable Officer, I have responsibility for reviewing the
effectiveness of the system of internal control. My review of the effectiveness
of the system of internal control is informed by the work of the internal
auditors, clinical audit and the executive managers and clinical leads within
the NHS trust who have responsibility for the development and maintenance of
the internal control framework. I have drawn on the information provided in
this annual report and other performance information available to me. My review
is also informed by comments made by the external auditors in their management
letter and other reports. I have been advised on the implications of the result
of my review of the effectiveness of the system of internal control by the
Board, the Audit Committee and the Quality and Risk Committee, as well as sub
committees and others within the group structure, and a plan to address
weaknesses and ensure continuous improvement of the system is in place.
My review is informed in a number of ways. The Head of Internal Audit
provides me with an opinion on the overall arrangements for gaining assurance
through the Board Assurance Framework and on the controls reviewed as part of
the internal audit work. Executive managers within the organisation who have
responsibility for the development and maintenance of the system of internal
control provide me with assurance. The Board Assurance Framework itself
provides me with evidence of the effectiveness of controls that manage risks to
the organisation.
My review was also informed
by:
- delivery of audit plans by external and internal
auditors
- unconditional registration with the Care Quality
Commission
The Head of Internal Audit is required to provide an annual opinion on
the systems and processes of internal control employed in the trust. The Head
of Internal Audit Opinion provided a rating of "significant assurance with improvement required," the second highest rating an organisation can receive.
During the year the trust has made real and sustainable improvements to
its control and governance arrangements.
It has embedded further structure and guidance in relation to the understanding
and management of risk and clinical audit and further improvements to re-align
and enhance its governance arrangements relating to population health
management, health inequalities and digital inequalities.
Audit Committee
The Audit Committee meets quarterly and has a key role in providing
assurance to the trust Board on the control mechanisms that are in place across
the trust. The Audit Committee reviews the adequacy of all risk and control
related disclosure statements together with any accompanying head of internal
audit statement prior to endorsement by the trust Board. The committee receives regular update reports
from, among others, the Director of Finance and Business Intelligence, the
Deputy Director of Corporate Governance and both internal and external audit.
During the year the Committee gave particular consideration to the
development of fraud prevention and incorporating nationally identified fraud
risks into the trust risk management processes, actions identified through
internal audits and governance and assurance of vaccination sites and processes.
LCHS continued to undertake the role of lead provider and the trust’s CQC
registration for the provision of covid vaccinations through the two large
vaccination centres, in collaboration with system partners, and for the roll
out of vaccinations to school aged children and young people, as per the
nationally stipulated cohorts.
The committee continues to develop and enhance mechanisms to gain
assurance on all areas that come within its terms of reference, which were also
reviewed and amended during 2021-22. It approves a programme of work by
internal audit (Grant Thornton LLP), external audit (Mazars LLP) and counter
fraud (Counter Fraud Plus Collaborative), based on a risk analysis and clinical
assurance mechanisms, to allow it to provide the necessary assurance to the trust Board on an on-going basis.
Names of
directors forming an audit committee
- Alan Kent – chair
- Gail Shadlock – non-executive director
- Malcolm Burch – non-executive director (from 1 May 2021)
- Sam Wilde – executive director of finance and business intelligence
Also in attendance:
- Deputy Director of Finance, Performance and Information
- Deputy Director of Corporate Governance
- Medical Director/ Deputy Medical Director
- Client manager (internal audit)
- Director (external audit)
- Local Counter Fraud Specialist
Quality and Risk Committee (Q&RC)
The Quality and Risk Committee met each month by virtual means, inclusive
of a development session in December 2021. The Committee provides assurance to
the trust Board that appropriate and effective governance mechanisms are in
place for all aspects of quality and risk including: safety of clinical
services, management of risk, understanding and acting on patient feedback, clinical
effectiveness including health outcomes, learning from incidents and complaints,
delivery of the Clinical Strategy, equality, diversity, inclusion and health
inequalities (access to services, impact of change on patients and the public),
population health management, verbal updates, as necessary, from Non-Executive
Director Champions (Freedom to Speak Up and Doctor’s Disciplinary), compliance
with national, regional and local regulatory requirements.
Finance, Performance, People and Innovation Committee (FPPIC)
The committee, with the arrival of a new chair in
July 2021, reviewed and updated the committee name to more closely reflect the
scope of the committee’s accountabilities and priorities of the committee and
organisation to be people-centred and innovative as well as driving excellent
financial management and performance. The name was updated from the Finance,
Performance and Investment Committee to the Finance, Performance, People and
Innovation Committee. The committee met monthly throughout the year, with a
development session in December 2021.
The committee
provides assurance to the trust Board that appropriate and effective governance
mechanisms are in place for all aspects of: financial
and operational strategy, policy, management and reporting, people and
innovation, health and safety, performance management and reporting, procurement
strategy and investment policy, management and reporting, integrated business
planning, associated strategies, digital health and cyber security, security
management, information governance, equality, diversity, inclusion and health
inequalities, population health management (performance, finance, data and
staff aspects), verbal updates, as necessary, from Non-Executive
Director Champions and compliance with
national, regional and local regulatory requirements.
Trust Leadership Team
The Trust Leadership Team (TLT) continued to meet throughout the year,
reducing meetings to twice monthly. TLT comprises of the Maz Fosh (Chief
Executive and chair), all executive directors (Tracy Pilcher, Sam Wilde, Ceri
Lennon and Yvonne Owen) all deputy directors and for extended meetings
divisional leads and heads of service join meetings. TLT oversee the running of
trust business and connect into committees and trust Board as required. The
team also hold responsibility for the corporate operational risk register.
Emergency Arrangements
On 24 December 2021 NHS England and NHS Improvement issued guidance to
NHS trusts in light of the new Omicron Covid variant, the rapid spread and
increase in covid positive presentations and the announcement on 13 December to
significantly step-up the roll-out of covid vaccinations across the country. LCHS
did not step committees or trust Board meetings down at this time, although in
the January 2022 board session reducing the burden interim governance
arrangements were approved to step down non-essential assurance groups and operate
condensed agendas. From the beginning of March meetings and functions that had
been temporarily suspended progressed to re-commencing.
In conclusion, I am assured that no significant control issues existed
within Lincolnshire Community Health Services NHS Trust during the 2021-22
year.
Maz Fosh, Chief Executive
Lincolnshire Community Health Services NHS Trust
Date: 16 June 2022
Annual Governance Statement page list
-
This section of the annual report will cover: welcome from the Chair, Trust purpose, about the Trust, our work, our strategic aims and objectives, and the LCHS way.
-
This section of the annual report will cover: An overview by Maz Fosh, Chief Executive, LCHS 2021/22 key facts and figures, financial performance, highlights of the year, summary of LCHS structure and the services provided, challenges facing healthcare in Lincolnshire, Long Term Plan priorities and quality summary of performance
-
This section of the annual report will cover: Scope of responsibilities and the risk and control framework, freedom to speak up, system working and partnerships, review of economy, efficiency and effectiveness of the use of resources directors’ report - Composition of the Board of Directors and review of effectiveness.
-
This section of the annual report will cover: Board members and senior management remuneration (subject to audit), salaries and allowances for the year ending 31 March 2022 (subject to audit), salaries and allowances for the year ending 31 March 2021 (subject to audit), pension benefits for the year ending 31 March 2022 (subject to audit), pension benefits for the year ending 31 March 2021 (subject to audit), NHS Pensions Data, Cash Equivalent Transfer Values, real increase in CETV, relationship between the remuneration report and exit packages, severance payments and off-payroll engagements disclosures, remuneration policy for directors and senior managers, compensation on early retirement or for loss of office, payments to past directors, fair pay disclosure (subject to audit), sharing of senior members of staff, exit packages (subject to audit), off-payroll engagements (subject to audit),staff report, staff numbers and costs, NHS Staff Survey results, health and safety at work, staff sickness and staff turnover data and expenditure on consultancy.
-
This section of the annual report will cover the financial statements for 2021-22.